Prediction of prostate cancer recurrence using quantitative phase imaging: Validation on a general population
暂无分享,去创建一个
Gabriel Popescu | Virgilia Macias | Krishnarao Tangella | André Kajdacsy-Balla | Shamira Sridharan | Jonathan Melamed | J. Melamed | G. Popescu | A. Kajdacsy-Balla | Krishnarao V. Tangella | V. Macias | Shamira Sridharan | Max Xiangtian Kong | Emily Dube | M. Kong | E. Dubé
[1] P. Escobar,et al. Diagnostic efficacy of optical coherence tomography in the management of preinvasive and invasive cancer of uterine cervix and vulva , 2003, International Journal of Gynecologic Cancer.
[2] Ashok Patel,et al. The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource , 2004, BMC Bioinformatics.
[3] J. Rogers,et al. Spatial light interference microscopy (SLIM) , 2010, IEEE Photonic Society 24th Annual Meeting.
[4] M. Cooperberg,et al. A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy , 2011 .
[5] L. Chung. Fibroblasts are critical determinants in prostatic cancer growth and dissemination , 1991, Cancer and Metastasis Reviews.
[6] Zhuo Wang,et al. Scattering-phase theorem. , 2011, Optics letters.
[7] Timothy J Wilt,et al. Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.
[8] S. Loening,et al. Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: Analytical aspects , 1998, The Prostate.
[9] I. Thompson,et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. , 1998, The New England journal of medicine.
[10] C. Compton,et al. High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography. , 2000, Gastrointestinal endoscopy.
[11] S. D. Babacan,et al. White-light diffraction tomography of unlabelled live cells , 2014, Nature Photonics.
[12] M. Cooperberg,et al. The CAPRA‐S score , 2011, Cancer.
[13] G. Ayala,et al. Reactive stroma in prostate cancer progression. , 2001, The Journal of urology.
[14] M. Becich,et al. Practical aspects of planning, building, and interpreting tissue microarrays: The Cooperative Prostate Cancer Tissue Resource experience , 2007, Journal of Molecular Histology.
[15] Zhuo Wang,et al. Measuring the scattering parameters of tissues from quantitative phase imaging of thin slices. , 2011, Optics letters.
[16] G. Gelikonov,et al. In vivo endoscopic OCT imaging of precancer and cancer states of human mucosa. , 1997, Optics express.
[17] A. Hoznek,et al. Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors , 2011, World Journal of Urology.
[18] William J Catalona,et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.
[19] Michael W Kattan,et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. , 2002, The Journal of urology.
[20] R. Scott,et al. Long-Term Results , 2001 .
[21] V. Backman,et al. Partial-wave microscopic spectroscopy detects subwavelength refractive index fluctuations: an application to cancer diagnosis. , 2009, Optics letters.
[22] Freddy T. Nguyen,et al. Intraoperative evaluation of breast tumor margins with optical coherence tomography. , 2009, Cancer research.
[23] John F Ward,et al. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. , 2003, The Journal of urology.
[24] Acknowledgements , 1992, Experimental Gerontology.
[25] C. Roehrborn,et al. Pre‐treatment biomarker levels improve the accuracy of post‐prostatectomy nomogram for prediction of biochemical recurrence , 2009, The Prostate.
[26] Barry R. Masters,et al. Quantitative Phase Imaging of Cells and Tissues , 2012 .
[27] L. C. Henyey,et al. Diffuse radiation in the Galaxy , 1940 .
[28] P. Andersen,et al. OCT imaging of skin cancer and other dermatological diseases , 2009, Journal of biophotonics.
[29] Michael W Kattan,et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] K. Eliceiri,et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. , 2011, The American journal of pathology.
[31] R. Sutherland,et al. Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma , 2003, Cancer.
[32] A W Partin,et al. Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.
[33] M. Datta,et al. A simple computer program for calculating PSA recurrence in prostate cancer patients , 2004, BMC urology.
[34] Zhuo Wang,et al. Tissue refractive index as marker of disease. , 2011, Journal of biomedical optics.
[35] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[36] Rohit Bhargava,et al. Quantifying collagen structure in breast biopsies using second-harmonic generation imaging , 2012, Biomedical optics express.
[37] C. Roehrborn,et al. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. , 2007, The Journal of urology.
[38] Anirban P. Mitra,et al. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. , 2013, The Journal of urology.
[39] C. Roehrborn,et al. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy , 2004, BJU international.
[40] Gabriel Popescu,et al. Prediction of Prostate Cancer Recurrence Using Quantitative Phase Imaging , 2015, Scientific Reports.
[41] Misop Han,et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.
[42] Anirban P. Mitra,et al. Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy , 2013, PloS one.
[43] Andrew J Vickers,et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] J. Izatt,et al. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. , 2000, Gastrointestinal endoscopy.
[45] J. Mohler,et al. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer , 1997, Clinical & Experimental Metastasis.
[46] E. Graves. National Hospital Discharge Survey. , 1989, Vital and health statistics. Series 13, Data from the National Health Survey.
[47] Ji Yi,et al. Ultrastructural alterations in field carcinogenesis measured by enhanced backscattering spectroscopy , 2013, Journal of biomedical optics.
[48] Pierre I Karakiewicz,et al. An updated catalog of prostate cancer predictive tools , 2008, Cancer.
[49] D. Rowley. What Might A Stromal Response Mean to Prostate Cancer Progression? , 1998, Cancer and Metastasis Reviews.
[50] A. Partin,et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. , 2001, The Urologic clinics of North America.
[51] Simon A. Williams,et al. Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? , 2007, The Prostate.
[52] G W Becker,et al. Growth regulation of prostatic stromal cells by prostate-specific antigen. , 1999, Journal of the National Cancer Institute.
[53] S. Bastacky,et al. Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography. , 2003, Optics letters.
[54] H. Moch,et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. , 2000, Human pathology.
[55] R. Bhargava,et al. Improving Prediction of Prostate Cancer Recurrence using Chemical Imaging , 2015, Scientific Reports.
[56] Oleg Nadiarnykh,et al. Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy , 2010, BMC Cancer.
[57] G. Ayala,et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] P. Scardino,et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[59] Michael W Kattan,et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] M. Terris,et al. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. , 2014, European urology.
[61] S. Byun,et al. Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade , 2012, Korean journal of urology.
[62] R. William G. Watson,et al. Biomarker research in prostate cancer—towards utility, not futility , 2011, Nature Reviews Urology.